	US 12,077,725 B2
	Ionizable cationic lipids
Daryl C. Drummond, Lincoln, MA (US); Dmitri B. Kirpotin, San Francisco, CA (US); and Mark E. Hayes, Mill Valley, CA (US)
Assigned to Akagera Medicines, Inc., Boxford, MA (US)
Filed by Akagera Medicines, Inc., Boxford, MA (US)
Filed on Dec. 12, 2022, as Appl. No. 18/064,565.
Application 18/064,565 is a continuation of application No. 17/456,567, filed on Nov. 24, 2021, granted, now 11,591,544.
Claims priority of provisional application 63/118,534, filed on Nov. 25, 2020.
Prior Publication US 2023/0126953 A1, Apr. 27, 2023
Int. Cl. C11C 3/00 (2006.01); C07D 317/28 (2006.01); C07F 9/09 (2006.01)

CPC C11C 3/003 (2013.01) [C07D 317/28 (2013.01); C07F 9/091 (2013.01)]

20 Claims

1. A compound selected from the group consisting of AKG-UO-1, AKG-UO-1A, AKG-UO-1B, AKG-UO-2, AKG-UO-4, AKG-UO-4A, AKG-UO-5, AKG-UO-6, AKG-UO-7, AKG-UO-8, AKG-UO-9, AKG-UO-10, Compound 17, Compound 18, Compound 19, Compound 23, Compound 24, and Compound 25: